Filing Details
- Accession Number:
- 0001213900-21-018561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-30 11:43:49
- Reporting Period:
- 2021-03-26
- Accepted Time:
- 2021-03-30 11:43:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733413 | Tff Pharmaceuticals Inc. | TFFP | () | TX |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611241 | Lung Therapeutics, Inc. | 2600 Via Fortuna, Suite 360 Austin TX 78746 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-26 | 715,000 | $14.00 | 2,235,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
